StemCells, Inc. Announces Webcast to Discuss Fourth Quarter 2015 Financial Results
15 mars 2016 16h05 HE
|
StemCells, Inc.
NEWARK, Calif., March 15, 2016 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing novel cell-based therapeutics for the treatment of serious central nervous...
StemCells, Inc. Announces Closing of $8 Million Public Offering
14 mars 2016 17h19 HE
|
StemCells, Inc.
NEWARK, Calif., March 14, 2016 (GLOBE NEWSWIRE) -- StemCells, Inc. (NASDAQ:STEM) today announced that it has closed its previously announced offering of common stock and warrants. The Company sold a...
StemCells, Inc. Announces Pricing of Public Offering to Raise $8.1 Million
09 mars 2016 09h23 HE
|
StemCells, Inc.
NEWARK, Calif., March 09, 2016 (GLOBE NEWSWIRE) -- StemCells, Inc. (NASDAQ:STEM) today announced the pricing of an underwritten public offering of common stock, Series A Warrants and Series B...
StemCells, Inc. Announces Proposed Public Offering of Common Stock and Warrants
08 mars 2016 17h00 HE
|
StemCells, Inc.
NEWARK, Calif., March 08, 2016 (GLOBE NEWSWIRE) -- StemCells, Inc. (NASDAQ:STEM) today announced that it intends to offer and sell common stock, Series A Warrants and Series B Warrants, subject to...
StemCells, Inc., Pathway™ Study in Cervical Spinal Cord Injury Featured in Pittsburgh Post-Gazette
26 févr. 2016 16h05 HE
|
StemCells, Inc.
NEWARK, Calif., Feb. 26, 2016 (GLOBE NEWSWIRE) -- StemCells, Inc. (NASDAQ:STEM), a world leader in the research and development of cell-based therapeutics for the treatment of central nervous system...
Ian Massey, President and CEO of StemCells, Inc., to Participate on a Regenerative Medicine Panel at Source Capital Group’s 2016 Disruptive Growth and Healthcare Conference
04 févr. 2016 16h05 HE
|
StemCells, Inc.
NEWARK, Calif., Feb. 04, 2016 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that Ian Massey, President and CEO of StemCells, Inc., will participate on a regenerative medicine...
CORRECTING and REPLACING -- StemCells, Inc. to Participate at the 2016 BIO CEO Conference and Source Capital Group’s 2016 Disruptive Growth and Healthcare Conference
28 janv. 2016 11h15 HE
|
StemCells, Inc.
NEWARK, Calif., Jan. 28, 2016 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by StemCells, Inc. (Nasdaq:STEM), please note that in the third paragraph of the release,...
StemCells, Inc. to Participate at the 2016 BIO CEO Conference and Source Capital Group’s 2016 Disruptive Growth and Healthcare Conference
28 janv. 2016 08h05 HE
|
StemCells, Inc.
NEWARK, Calif., Jan. 28, 2016 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that management will make presentations on the Company's programs, pipeline and operations at two...
StemCells, Inc. CEO Martin McGlynn Passes Baton to President and COO Ian Massey
11 janv. 2016 08h05 HE
|
StemCells, Inc.
NEWARK, Calif., Jan. 11, 2016 (GLOBE NEWSWIRE) -- StemCells, Inc. (NASDAQ:STEM), a world leader in the research and development of cell-based therapeutics for the treatment of central nervous system...
StemCells, Inc. to Participate at the 8th Annual Biotech Showcase Investor Conference
06 janv. 2016 08h05 HE
|
StemCells, Inc.
NEWARK, Calif., Jan. 06, 2016 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that management will make a presentation on the Company's programs, pipeline and operations at the 8th...